MRI measurements of vessel calibre in tumour xenografts: Comparison with vascular corrosion casting

Microvascular Research

Volumn 84, Issue 3, 2012, Pages 323-329

  Burrell, Jake S ^a   Bradley, Robert S ^b   Walker Samuel, Simon ^a,c   Jamin, Yann ^a   Baker, Lauren C J ^a   Boult, Jessica K R ^a   Withers, Philip J ^b   Halliday, Jane ^d   Waterton, John C ^d   Robinson, Simon P ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; N ACETYLCOLCHINOL PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD VESSEL PARAMETERS; COLORECTAL TUMOR; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VIVO STUDY; MICRO-COMPUTED TOMOGRAPHY; MICROVASCULAR CORROSION CASTING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERIZATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; VESSEL SIZE INDEX;

ANIMALS; BIOLOGICAL MARKERS; CELL LINE, TUMOR; CORROSION CASTING; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; ORGANOPHOSPHORUS COMPOUNDS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; X-RAY MICROTOMOGRAPHY;

ANIMALIA; MUS;

EID: 84868108492     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2012.08.001     Document Type: Article

References (42)

1. Abbas B., et al. Radiation induced changes in the blood capillaries of rat duodenal villi: a corrosion cast, light and transmission electron microscopical study. J. Submicrosc. Cytol. Pathol. 1990, 22:63-70.
2. Beaumont M., et al. Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI. J. Cereb. Blood Flow Metab. 2009, 29:1714-1726.
3. Blakey D.C., et al. Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. Clin. Cancer Res. 2002, 8:1974-1983.
4. Bradley D.P., et al. Correlation of MRI biomarkers with tumor necrosis in Hras5 tumor xenograft in athymic rats. Neoplasia 2007, 9:382-391.
5. Bradley R.S., et al. An examination of phase retrieval algorithms as applied to phase contrast tomography using laboratory sources. Developments in X-ray Tomography VII, San Diego 2010, S.R. Stock (Ed.).
6. Douma K., et al. Evaluation of magnetic resonance vessel size imaging by two-photon laser scanning microscopy. Magn. Reson. Med. 2010, 63:930-939.
7. El Emir E., et al. Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas. Cancer Res. 2007, 67:11896-11905.
8. Farrar C.T., et al. In vivo validation of MRI vessel caliber index measurement methods with intravital optical microscopy in a U87 mouse brain tumor model. Neuro Oncol. 2010, 12:341-350.
9. Ferretti S., et al. Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure. Clin. Cancer Res. 2005, 11:7773-7784.
10. Folarin A.A., et al. Three-dimensional analysis of tumour vascular corrosion casts using stereoimaging and micro-computed tomography. Microvasc. Res. 2010, 80:89-98.
11. Howe F.A., et al. Vessel size index magnetic resonance imaging to monitor the effect of antivascular treatment in a rodent tumor model. Int. J. Radiat. Oncol. Biol. Phys. 2008, 71:1470-1476.
12. Jung C.W., Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imaging 1995, 13:661-674.
13. Just N. Histogram analysis of the microvasculature of intracerebral human and murine glioma xenografts. Magn. Reson. Med. 2011, 65:778-789.
14. Kak A.C., Slaney M. Principles of Computerized Tomographic Imaging 1988, IEEE Press, New York.
15. Keyriläinen J., et al. Phase-contrast X-ray imaging of breast. Acta Radiol. 2010, 51:866-884.
16. Konerding M.A., et al. The vascular system of xenotransplanted tumors - scanning electron and light microscopic studies. Scanning Microsc. 1989, 3:327-335.
17. Kostourou V., et al. Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging. Cancer Res. 2003, 63:4960-4966.
18. Landuyt W., et al. In vivo animal functional MRI: improved image quality with a body-adapted mold. J. Magn. Reson. Imaging 2002, 16:224-227.
19. Lemasson B., et al. Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects. NMR Biomed. 2011, 24:473-482.
20. Lemasson, B., et al., in press. In vivo imaging of vessel diameter, size, and density: a comparative study between MRI and histology. Magn. Reson. Med. http://dx.doi.org/10.1002/mrm.24218.
21. Malcontenti-Wilson C., et al. Combretastatin A4 prodrug study of effect on the growth and the microvasculature of colorectal liver metastases in a murine model. Clin. Cancer Res. 2001, 7:1052-1060.
22. Miodonski A., et al. Elekronenmikroskopie von Plastik-Korrosions-Praparaten: Morphologische Unterschiede zwischen Arterien und Venen. BEDO 1976, 9:435-442.
23. Murakami T. Application of the scanning electron microscope to the study of the fine distribution of the blood vessels. Arch. Histol. Jpn. 1971, 32:445-454.
24. Nielsen, T., 2007. Tumour vascularity assessed by MRI. Faculty of Health Sciences, University of Aarhus. PhD Thesis.
25. O'Connor J.P., et al. Quantifying antivascular effects of monoclonal antibodies to vascular endothelial growth factor: insights from imaging. Clin. Cancer Res. 2009, 15:6674-6682.
26. 2 quantification. Magn. Reson. Med. 2011,66:144-153.
27. Robinson S.P., et al. Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. Br. J. Cancer 2003, 88:1592-1597.
28. Robinson S.P., et al. Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistry. J. Magn. Reson. Imaging 2003, 17:445-454.
29. Robinson S.P., et al. Susceptibility contrast magnetic resonance imaging determination of fractional tumor blood volume: a noninvasive imaging biomarker of response to the vascular disrupting agent ZD6126. Int. J. Radiat. Oncol. Biol. Phys. 2007, 69:872-879.
30. Robinson S.P., et al. The effects of tumor-derived platelet-derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI. Int. J. Cancer 2008, 122:1548-1556.
31. Salmon H.W., et al. Evaluations of vascular disrupting agents CA4P and OXi4503 in renal cell carcinoma (Caki-1) using a silicon based microvascular casting technique. Eur. J. Cancer 2006, 42:3073-3078.
32. Tropres I., et al. Vessel size imaging. Magn. Reson. Med. 2001, 45:397-408.
33. Tropres I., et al. In vivo assessment of tumoral angiogenesis. Magn. Reson. Med. 2004, 51:533-541.
34. Ungersma S.E., et al. Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magn. Reson. Med. 2010, 63:1637-1647.
35. Valable S., et al. Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. NMR Biomed. 2008, 21:1043-1056.
36. Vogel-Claussen J., et al. Diffusion-weighted and macromolecular contrast enhanced MRI of tumor response to antivascular therapy with ZD6126. Cancer Biol. Ther. 2007, 6:1469-1475.
37. Wade T.P., Kozlowski P. Longitudinal studies of angiogenesis in hormone-dependent Shionogi tumors. Neoplasia 2007, 9:563-568.
38. Walker-Samuel S., et al. Bayesian estimation of changes in transverse relaxation rates. Magn. Reson. Med. 2010, 64:914-921.
39. Walker-Samuel S., et al. Non-invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts. Int. J. Cancer 2012, 130:1284-1293.
40. Waterton J.C., Pylkkanen L. Qualification of imaging biomarkers for oncology drug development. Eur. J. Cancer 2012, 48:409-415.
41. Workman P., et al. Guidelines for the welfare and use of animals in cancer research. Br. J. Cancer 2010, 102:1555-1577.
42. Yablonskiy D.A., Haacke E.M. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn. Reson. Med. 1994, 32:749-763.